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Received October 9, 2014; accepted March 26, 2015AbstractBackground: Osteonecrosis of the femoral head (ONFH) is an important indication for total hip arthroplasty in Taiwan. We demonstrated the
etiologies of ONFH and outcomes based on stratification of patients according to different etiologies.
Methods: We reviewed medical records and images from January 2000 to May 2010 in our database with the diagnosis of “osteonecrosis of the
femoral head.” We categorized all patients into different etiologies, including corticosteroid, alcohol, and idiopathic. All patients received
subsequent follow up for ipsilateral precollapse ONFH and contralateral disease-free femoral head status after initial diagnosis.
Results: Of the 1153 patients who had undergone 1674 hip surgeries including core decompression and total hip replacement, alcohol use was
the most prevalent etiology in our population (45.2%). Patients with corticosteroid- and alcohol-associated ONFH were younger and more likely
to have bilateral disease. Patients with alcohol- or steroid-associated ONFH were found to have a higher rate of contralateral disease and faster
progression of precollapse ONFH than patients who had or had not undergone core decompression.
Conclusion: Alcohol use had the greatest impact on ONFH in our population. Nonidiopathic ONFH patients had the worst outcome. Under-
standing the nature of progression of ONFH and incidence of contralateral disease may provide great prognostic value to detect and perform
early intervention.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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More than 4000 primary total hip replacement (THR) sur-
geries are performed annually in Taiwan. Indications for pri-
mary THR in Taiwan have been reported to be greatly
different from those in Norway and Sweden. Instead of oste-
oarthritic (OA) hip, osteonecrosis of the femoral head (ONFH)Conflicts of interest: The authors declare that they have no conflicts of interest
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1726-4901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Assis the leading indication for primary THR, accounting for
46.9% of all indications.1e3 For a patient with precollapse
ONFH, conservative treatment or surgical intervention would
be expected to prolong the duration to progress to the post-
collapse status. Hip arthroplasty remains the main choice of
treatment in patients with postcollapse ONFH. These patients
are generally young, with great functional requirement, and a
long life expectancy. Revision arthroplasty could be expected
in their lifetime because of wear, loosening, or breakage of the
implants, which would greatly impair the life quality of the
patient and increase the burden on the medical service system.
There are several risk factors associated with the collapse
of the femoral head, including the initial stage, lesion size,
location, and sickle cell anemia.4e9 Goker and Block10 statedociation. All rights reserved.
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hip indicated risk of progression to symptomatic disease or a
more advanced stage. However, there had not been a study that
compared the outcome of patients with ONFH among
etiologies.
The aim of this study was to show the demographic data in
our population and prognosis for ONFH patients with different
etiologies. First, we demonstrated the prevalence of etiologies
in our population. We also demonstrated the age at which
patients had undergone surgeries and the proportion of bilat-
eral disease. Second, we demonstrated the incidence of
contralateral ONFH when unilateral ONFH was detected.
Third, among the study groups, we showed the survival rate of
patients with precollapse ONFH and their progress to post-
collapse ONFH.
2. Methods
Medical records and all images including plain film, nuclear
scan, or magnetic resonance image from a single medical
center database, from January 2000 to May 2010, with the
diagnosis of “osteonecrosis of femoral head” were reviewed by
a single experienced orthopedist. Informed consent was ob-
tained from each participant for this retrospective study. A total
of 1500 patients fulfilled the search criteria that they had been
treated as outpatients or inpatients. Patients with diagnosis of
OA hip, rheumatoid arthritis of the hip, ankylosing spondy-
loarthropathy of the hip, developmental dysplasia of the hip,
pigmented villonodular synovitis, LeggeCalveePerthes dis-
ease or femoral neck fracture but wrongly recorded as ONFH,
missing images and medical records, or trauma-associated
ONFH were excluded. We excluded 93, 110, and 144 pa-
tients because of wrong diagnosis, missing data, and trauma-
associated ONFH, respectively. A total of 1153 patients who
had undergone 1674 surgeries, including 354 core decom-
pression surgeries and 1320 hip arthroplasty surgeries, were
included. Patients who experienced hip fractures with subse-
quent ONFH were defined as trauma-associated ONFH. For
precollapse ONFH cases, we performed core decompression
without bone grafting or with nonvascularized trochanteric
bone grafting. For postcollapse ONFH cases, hemiarthroplasty
or total hip arthroplasty was performed. After the surgery, we
arranged monthly follow ups during the first 3 months, then
once every 3 months up to 1 year, and annually thereafter.
During the follow up, plain films or magnetic resonance im-
aging (MRI) was taken to check for new onset or progression
of the disease. If unilateral ONFH was found on the image
before surgery, all subsequent images were checked for
contralateral ONFH. The interval between the onsets of bilat-
eral ONFH was recorded. For patients with precollapse ONFH,
duration to progress to postcollapse ONFH was recorded.
All patients were categorized into the following three
groups: alcohol users, corticosteroid users, and idiopathic. We
defined alcohol users using the records of daily consumption
of different types of alcoholic drinks including beer, wine, and
liquors. Average daily amount was estimated as g of ethanol/
d by multiplying average daily consumption of liquors inmilliliters by the percentage of ethanol contained in the li-
quors. We defined corticosteroid users using the records of
regular follow up at the outpatient department with a diagnosis
indicated for regular corticosteroid use. To define idiopathic
ONFH, we first excluded alcohol- or corticosteroid-associated
ONFH. We reviewed medical records to rule out additional
risk factors including Caisson disease, Gaucher disease, sickle
cell anemia, vasculitis, polycythemia, coagulopathies, and
disseminated intravascular coagulation. Patients were then
recorded as idiopathic ONFH. In all three groups, sex, weight,
height, body mass index (BMI), and age of patients who had
undergone core decompression or arthroplasty were recorded.
Comparisons of patient characteristics were performed
using chi-square test and analysis of variance with Tukey
honest significant difference test for categorical and contin-
uous variables, respectively. Univariate survival outcomes for
patients with precollapse ONFH and contralateral disease-free
femoral head status were estimated using the KaplaneMeier
method and compared using log-rank statistics. To determine
whether observed differences in survival were independently
associated with different etiologies, multivariate analysis was
performed using the Cox proportional hazards model. In
addition to etiologies, additional study variables included in
the model were age, sex, body height, body weight, and
whether the patient had undergone core decompression sur-
gery. We used SPSS software version 17.0 (SPSS Inc., Chi-
cago, IL, USA) for all statistical calculations.
3. Results
Patients underwent core decompression and hip arthro-
plasty surgeries at the average ages of 44.5 years and 50.2
years, respectively. Among these patients, the alcohol con-
sumption group accounted for the most cases of ONFH
(45.2%) in our population. The steroid (21.7%) and idiopathic
(33.1%) groups accounted for the rest. Overall, 663 (59.1%)
patients had bilateral ONFH. The proportion of bilateral
ONFH was higher in the corticosteroid group (72.4%) than in
the alcohol (62.5%) and idiopathic groups (45.3%). Patients
who had undergone surgery for an unknown indication at an
outside hospital in one hip and presented with ONFH in the
contralateral hip were recorded “not determined” (Fig. 1).
Among the 93 patients with other diagnosis but wrongly
recorded as ONFH, the most common diagnosis was OA hip
(59.0%). The most common indication for corticosteroid use
was systemic lupus erythematosus (SLE; 43.6%; Table 1).
Among the patients categorized as alcohol-associated ONFH,
the average daily alcohol consumption was 86.21 ± 109.8 g
(range 15e556 g).
Concerning the demographic data of these patients (Table
2), we found male preponderance (69.3%). Among the male
patients, alcohol (62.1%) was the most important risk factor
for ONFH. By contrast, idiopathic (49.2%) and corticosteroid-
associated ONFH (43.7%) were more prevalent in female
patients. Body height and weight were higher in the alcohol
group than in others, however, BMI was not different. The
average ages for patients undergoing core decompression and
Fig. 1. CONSORT flow diagram detailing the origin of the study cohort. ONFH ¼ osteonecrosis of the femoral head.
Table 1
Indications for corticosteroid in the cohort.
Indications No. (%)
SLE 109 (43.6)
Hematologic cancer 28 (11.2)
Asthma/COPD 28 (11.2)
Transplantation 16 (6.4)
Nephritic/nephrotic syndrome 11 (4.4)
Intracranial lesion 9 (3.6)
RA 8 (3.2)
Multiple sclerosis 6 (2.4)
Adrenal insufficiency 6 (2.4)
Eczema/urticaria 6 (2.4)
AS 3 (1.2)
Sj€ogren syndrome 3 (1.2)
Dermatomyositis/polymyositis 3 (1.2)
Psoriasis 3 (1.2)
UC/CD 2 (0.8)
Migraine 2 (0.8)
Iritis 2 (0.8)
Others 5 (2)
Total 250 (100)
AS ¼ ankylosing spondylitis; CD¼Crohn's disease;
COPD ¼ chronic obstructive pulmonary disease; RA ¼ rheumatoid
arthritis; SLE ¼ systemic lupus erythematosus; UC ¼ ulcerative
colitis.
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respectively. Patients in the corticosteroid group were signif-
icantly younger when they had undergone core decompression
(38.2 ± 15.0 years) and hip arthroplasty (44.5 ± 17.0 years),
compared with those of the alcohol (44.9 ± 10.3 years,
47.8 ± 11.0 years) and idiopathic groups (52.0 ± 13.4 years,
58.6 ± 15.4 years).
The incidence curve of contralateral ONFH is shown in
Fig. 2. In idiopathic ONFH, 14.2%, 20.6%, 31.3%, 36.1%, and
43.3% of patients developed contralateral ONFH at 1 year, 2
years, 3 years, 4 years, and 5 years, respectively, after the
diagnosis of unilateral ONFH. In alcohol-associated ONFH,
23.4%, 31.7%, 41.5%, 48.3%, and 62.5% of patients devel-
oped contralateral ONFH at 1 year, 2 years, 3 years, 4 years,
and 5 years, respectively, after the diagnosis of unilateral
ONFH. In corticosteroid-associated ONFH, 31.0%, 47.3%,
56.8%, 62.4%, and 66.4% of patients developed contralateral
ONFH at 1 year, 2 years, 3 years, 4 years, and 5 years,
respectively, after the diagnosis of unilateral ONFH. The
incidence of developing contralateral ONFH was significantly
higher in corticosteroid- and alcohol-associated ONFH pa-
tients than in idiopathic ONFH patients ( p < 0.001). The mean
follow-up time was 2.94 years (range 1 month to 20 years).
Table 2
Demographic data of the study cohort.
Idiopathic Alcohol Steroid p Total
Sex <0.001
Male 208 (26.0) 496 (62.1) 95 (11.9) 799 (69.3)
Female 174 (49.2) 25 (7.1) 155 (43.7) 354 (30.7)
Total 1153 (100)
Height (cm) 160.7 ± 9.4 (136e191) a 167.9 ± 6.4 (151e187) b 160.0 ± 10.3 (135e182) a <0.001 163.5 ± 9.2 (135e191)
Weight (kg) 64.7 ± 12.1 (34e103) a 69.9 ± 12.0 (43e113) b 63.3 ± 15.1 (42e107) a <0.001 66.7 ± 12.6 (34e113)
BMI (kg/m2) 25.0 ± 3.9 (14.4e42.7) 24.8 ± 3.7 (15.8e41.8) 24.7 ± 5.2 (17.3e44.3) 0.604 24.9 ± 4.1 (14.4e44.3)
Core decompression <0.001
Number of hips 99 142 113 354
Age at operation (y) 52.0 ± 13.4 (27e83) a 44.9 ± 10.3 (23e81) a 38.2 ± 15.0 (15e82) c 44.5 ± 13.7 (15e83)
Arthroplasty <0.001
Number of hips 412 621 287 1320
Age at operation (y) 58.6 ± 15.4 (21e92) a 47.8 ± 11.0 (26e88) b 44.5 ± 17.0 (15e82) c 50.2 ± 14.9 (15e92)
Categorical values are expressed as n (%); continuous values are expressed in mean ± standard deviation, with range in parentheses.
a,b,c Different letters indicate significant difference across groups.
BMI ¼ body mass index.
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(Figs. 3Ae3C) in our study patients stratified by etiologies and
whether they had undergone core decompression. Overall,
patients with corticosteroid- and alcohol-associated ONFH
had more rapid progression to postcollapse ONFH
( p ¼ 0.001). Patients with idiopathic ONFH had slower pro-
gression to postcollapse ONFH than those with alcohol- or
corticosteroid-associated ONFH who had or had not under-
gone core decompression ( p ¼ 0.003 and p ¼ 0.015, respec-
tively). Among idiopathic ONFH patients who had not
undergone core decompression, 68.7%, 58.4%, 44.4%, 31.3%,
and 27.0% remained at precollapse ONFH at 1 year, 2 years, 3
years, 4 years, and 5 years, respectively, after the diagnosis.
Among alcohol-associated ONFH patients who had not un-
dergone core decompression, 58.0%, 39.6%, 31.8%, 26.9%,
and 24.0% remained at precollapse ONFH at 1 year, 2 years, 3Fig. 2. Incidence curve depicting contralateral osteonecrosyears, 4 years, and 5 years, respectively, after the diagnosis.
Among corticosteroid-associated ONFH patients who had not
undergone core decompression, 51.9%, 36.3%, 23.3%, 11.6%,
and 1.3% remained at precollapse ONFH at 1 year, 2 years, 3
years, 4 years, and 5 years, respectively, after the diagnosis.
Among patients with idiopathic ONFH who had undergone
core decompression, 77.0%, 66.2%, 45.1%, 40.7%, and 40.7%
were identified with precollapse ONFH at 1 year, 2 years, 3
years, 4 years, and 5 years, respectively, after the diagnosis.
Among patients with alcohol-associated ONFH who had un-
dergone core decompression, 56.5%, 33.6%, 30.2%, 26.8%,
and 22.1% were found with precollapse ONFH at 1 year, 2
years, 3 years, 4 years, and 5 years, respectively, after the
diagnosis. Among patients with corticosteroid-associated
ONFH who had undergone core decompression, 56.7%,
46.0%, 30.1%, 30.1%, and 30.1% were found with precollapseis of the femoral head (ONFH; n ¼ 644, p < 0.001).
Fig. 3. KaplaneMeier survivorship curve (based on stratification of etiologies) depicting progression to collapse after the diagnosis: (A) in all patients (n ¼ 637,
p ¼ 0.001); (B) in patients who had not undergone core decompression (n ¼ 356, p ¼ 0.003); and (C) in patients who had undergone core decompression (n ¼ 271,
p ¼ 0.015). ONFH ¼ osteonecrosis of the femoral head.
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respectively, after the diagnosis. The mean follow-up time was
1.54 years (range 1 month to 9 years).
Steroid and alcohol use were independently associated with
worse prognosis of developing contralateral ONFH [hazard
ratio (HR) 4.16, 95% confidence interval (CI) 2.06e8.38,
p < 0.001; HR 1.81, 95% CI 1.12e2.92, p ¼ 0.016, respec-
tively] on multivariate analysis. In addition, steroid and
alcohol use were independently associated with worse survival
of collapse of ipsilateral ONFH (HR 2.01, 95% CI 1.21e3.34,
p ¼ 0.007; HR 1.45, 95% CI 1.01e2.09, p ¼ 0.047, respec-
tively) on multivariate analysis. Core decompression surgery
was found to have borderline protective effect against collapse
of ipsilateral ONFH (HR 0.743, 95% CI 0.53e1.05, p ¼ 0.09).
Age, sex, body height, and body weight were not significantly
associated with worsened prognosis of developing contralat-
eral ONFH or collapse of ipsilateral ONFH.
4. Discussion
ONFH has been the leading indication for primary THR in
Taiwan,1 which is very different from that reported in Sweden
and Norway.2,3 This major difference illustrates the important
impact of ONFH in Taiwan. The etiology of ONFH has been
discussed in a Japanese nationwide epidemiologic survey.
Systemic corticosteroid and habitual alcohol use accounted for
51% and 31% of ONFH, respectively.11 A Korean nationwide
epidemiology survey reported a history of alcohol and corti-
costeroid use in 32.4% and 14.6% of ONFH patients,
respectively.12 Castro and Harris13 reported that corticosteroid
and alcohol use accounted for 40.1% and 36.6% of the causes
of ONFH, respectively. In our study, the most common etiol-
ogy of ONFH was alcohol (45.2%). Idiopathic ONFH and
corticosteroid-associated ONFH accounted for 33.1% and
21.7%, respectively. Our results were comparable with those
of the Korean epidemiology survey but different from those of
the Japanese study.11,12
Alcohol and corticosteroid use have been reported to be
risk factors of ONFH.11,13e17 The average ages at which
corticosteroid-associated ONFH patients had undergone core
decompression and hip arthroplasty were 38.2 years and 44.5
years, respectively. Corticosteroid-associated ONFH patients
were younger when they received core decompression and hip
arthroplasty, compared with those in the alcohol (44.9 years
and 47.8 years) and idiopathic groups (52.0 years and 58.6
years). Castro and Harris13 reported that the onset of ONFH in
the corticosteroid, alcohol, and idiopathic groups was at 39
years, 49 years, and 42 years, respectively. Jacobs18 also
demonstrated that alcohol-associated ONFH patients had an
average duration of alcohol abuse of 9.5 years. In that study,
28% of the patients were aged < 40 years and 76% were aged
< 50 years. ONFH has been reported to be an important
morbidity in the SLE population, with prevalence ranging
from 10.14% to 52%.16,19e22 Among our corticosteroid-
associated ONFH patients, SLE accounted for 43.6% (109
patients). The average age for SLE patients to undergo core
decompression and hip arthroplasty was 35.54 years and 36.79years, respectively. SLE accounted for the largest proportion
of this group, and the patients were much younger.
Alcohol was the most prevalent etiology of ONFH in our
population. Average daily amount of alcohol consumption was
86.2 g. It is interesting that there was a great male predomi-
nance (95.2%) among alcohol users. Further studies are
necessary to figure out whether this predominance was
because of the different proportion of habitual alcohol con-
sumption between sexes or a possible protective mechanism in
females against exposure to alcohol.
The overall proportion of bilateral ONFH was 59.1%. The
proportion of bilateral disease was 72.4% in corticosteroid-
associated ONFH patients, which is higher than the pro-
portions in patients with alcohol-associated ONFH (62.5%)
and idiopathic ONFH (45.3%). The proportion of bilateral
ONFH varied from 47% to 78.3% in different populations
indicated for corticosteroid use.15e17,23 Castro and Harris13
reported 49%, 40%, and 35% of bilateral disease at initial
presentation in corticosteroid-associated, alcohol-associated,
and idiopathic ONFH, respectively.13 We had subsequent
follow up in all patients, which might have led to the increase
in the proportion in all etiologies.
Various factors have been reported to increase the risk of
progress to postcollapse ONFH, including initial stage,6 lesion
location,4,7e9 lesion size,4,5,7e9 and sickle cell anemia.6 We
described the difference in outcome among etiologies. In our
findings, among the study groups, there was a significant
difference in the survival rate of precollapse ONFH patients
who did or did not receive core decompression. The initial
stages were not different between etiologies. Worse outcome
was noted in corticosteroid- and alcohol-associated ONFH
than in idiopathic ONFH. The 5-year survival rates were
27.0%, 24.0%, and 1.3%, respectively, in patients with idio-
pathic, alcohol-associated, and corticosteroid-associated
ONFH who had not undergone core decompression. In pa-
tients who had undergone core decompression, the 5-year
survival rates was 40.7%, 22.1%, and 30.1%, respectively, in
idiopathic, alcohol-associated, and corticosteroid-associated
ONFH. In our study, no other conservative or surgical treat-
ment except for core decompression without bone grafting or
with nonvascularized trochanteric bone graft was performed.
Persistent exposure to irritants in these patients as a necessity
for corticosteroid treatment in case of diseases or alcohol
addiction might lead to inferior outcome than in patients
without such exposure.
According to our study, ONFH presents frequently bilat-
erally, especially in alcohol and corticosteroid users. It was
possible to detect early contralateral disease when patients
presented initially with unilateral ONFH. No study has
demonstrated the incidence of contralateral ONFH among
etiologies. Goker and Block10 reported that initial positive
radiographic evidence of contralateral hip was likely to
correlate with subsequent progress of the disease after ipsi-
lateral THR. In addition, the author stated that asymptomatic
contralateral hip without radiographic evidence was not likely
to progress to symptomatic ONFH.10 In the 663 patients with
bilateral ONFH in our study, 215 patients (32.4%) were
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contralateral hip but developed subsequent contralateral
ONFH during the follow up. In addition, the proportion at the
5th year was higher in corticosteroid-associated ONFH
(66.4%) and alcohol-associated ONFH (62.5%) than in idio-
pathic ONFH (43.3%). Therefore, awareness of contralateral
early ONFH is important in patients presenting with unilateral
ONFH, especially in alcohol- and corticosteroid-associated
ONFH patients.
This study has several limitations. First, this was a retro-
spective study. Second, MRI was not available for all the pa-
tients during the follow up. For precollapse ONFH, the end
point was defined as collapse of the femoral head. This should
be adequately detected using plain films. However, it would be
expected to miss cases with contralateral Stage I ONFH if
MRI was not used as a screening tool. The true incidence of
contralateral ONFH should be higher. Third, the follow-up
period was relatively short (2.94 ± 2.75 years). Although the
collapse occurred mostly within the first few years following
the initial diagnosis, the survival curve of the longer term
might not be as accurate as the shorter term. Fourth, we
defined idiopathic ONFH by exclusion of alcohol- and
corticosteroid-associated ONFH. It should be recognized that
potential misclassification could occur even though the other
etiologies were extremely rare or had less impact compared
with alcohol and corticosteroid use. Finally, although we
attempted to improve the reliability of the definition of
alcohol- and corticosteroid-associated ONFH by documenta-
tion of average daily alcohol consumption and indication of
corticosteroid use, this definition is still insufficient. However,
exact dose and duration of alcohol and steroid use that leads to
ONFH has not yet been established.
In conclusion, alcohol had the greatest impact on ONFH in
our population. Patients who had corticosteroid or alcohol use
had earlier onset and bilateral disease, a higher rate of disease
progression, and onset of contralateral disease. Understanding
the disease nature of ONFH may provide great prognostic
value to detect and perform early intervention.
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